Characterization of EN-1078D, a poorly differentiated human endometrial carcinoma cell line: a novel tool to study endometrial invasion in vitro
2007

Characterization of a New Endometrial Carcinoma Cell Line EN-1078D

Sample size: 4 publication 10 minutes Evidence: moderate

Author Information

Author(s): Dery Marie-Claude, Van Themsche Celine, Provencher Diane, Mes-Masson Anne-Marie, Asselin Eric

Primary Institution: Université du Québec à Trois-Rivières

Hypothesis

The study aims to characterize the EN-1078D cell line to understand its properties related to endometrial cancer metastasis.

Conclusion

The EN-1078D cell line is a valuable tool for studying metastatic endometrial cancer due to its tumorigenic properties and sensitivity to chemotherapy.

Supporting Evidence

  • EN-1078D cells express both estrogen receptor isoforms and low levels of progesterone receptor B.
  • All nude mice developed tumors after subcutaneous injections of EN-1078D cells.
  • EN-1078D cells showed sensitivity to cisplatin and doxorubicin with specific IC50 values.

Takeaway

Researchers created a new cell line from a type of cancer to learn more about how it spreads and how to treat it better.

Methodology

The study involved cytological, molecular, and in vivo assays to characterize the EN-1078D cell line and its response to chemotherapy.

Potential Biases

Potential bias in the interpretation of results due to the use of a single cell line and specific experimental conditions.

Limitations

The study primarily focuses on a single cell line, which may not represent all endometrial carcinoma types.

Participant Demographics

The cell line was derived from a 52-year-old woman with poorly differentiated endometrial adenocarcinoma.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1477-7827-5-38

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication